| Literature DB >> 35206121 |
Małgorzata Wacławik1, Wojciech Rodzaj1, Bartosz Wielgomas1.
Abstract
Humans are exposed to numerous potentially harmful chemicals throughout their lifetime. Although many studies have addressed this issue, the data on chronic exposure is still lacking. Hence, there is a growing interest in methods and tools allowing to longitudinally track personal exposure to multiple chemicals via different routes. Since the seminal work, silicone wristbands (WBs) have been increasingly used to facilitate human exposure assessment, as using WBs as a wearable sampler offers new insights into measuring chemical risks involved in many ambient and occupational scenarios. However, the literature lacks a detailed overview regarding methodologies being used; a comprehensive comparison with other approaches of personal exposure assessment is needed as well. Therefore, the aim of this review is fourfold. First, we summarize hitherto conducted research that employed silicone WBs as personal passive samplers. Second, all pre-analytical and analytical steps used to obtain exposure data are discussed. Third, we compare main characteristics of WBs with key features of selected matrices used in exposure assessment, namely urine, blood, hand wipes, active air sampling, and settled dust. Finally, we discuss future needs of research employing silicone WBs. Our work shows a variety of possibilities, advantages, and caveats associated with employment of silicone WBs as personal passive samplers. Although further research is necessary, silicone WBs have already been proven valuable as a tool for longitudinal assessment of personal exposure.Entities:
Keywords: biomonitoring; exposome; human exposure; passive sampling; personal monitoring; silicone wristband
Mesh:
Substances:
Year: 2022 PMID: 35206121 PMCID: PMC8872583 DOI: 10.3390/ijerph19041935
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Comparison of attributes of exposure assessment methods with the use of WBs and biomonitoring.
Figure 2Possibilities of deployment of silicone wristbands (WBs). For references, see section “Emergence of silicone wristbands in exposure assessment”.
The listing of sampling information regarding studies carried out with the use of silicone.
| Publication Year | Sampling Year | Country * | Population | Population Age Range (<18 y.o) |
| Exposure Setting | Wearing Period [Days] | References |
|---|---|---|---|---|---|---|---|---|
| 2014 | NA | USA | NA | NA | <30 | ambient | 30 | [ |
| 2014 | NA | USA | NA | NA | 8 | occupational | 0.3, 1.3–1.6 | [ |
| 2015 | 2013 | USA | adults | NA | 50 | ambient | 7 | [ |
| 2016 | 2015 | USA | adults | NA | 40 | ambient | 5 | [ |
| 2016 | 2012/2013 | USA | children | 3–5 | 92 | ambient | 7 | [ |
| 2016 | 2014 | SEN | adults, children | NR | 35 | occupational | 5 | [ |
| 2017 | 2014 | PER | adults, children | ≥6 | 68 | ambient | 30–34 | [ |
| 2017 | NR | USA | adults | NA | 22 | ambient | 2 | [ |
| 2017 | NR | USA | children | 7–9 | 10 | ambient | 7 | [ |
| 2017 | 2012–2013 | USA | children | 3–5 | 77 | ambient | 7 | [ |
| 2018 | nd | USA | adults | NA | 19 | ambient | 21 | [ |
| 2018 | NR | USA | adults | NA | 22 | ambient | 2 | [ |
| 2018 | 2016 | BEL | adults | NA | 30 | ambient | 5 | [ |
| 2018 | 2016 | USA | adults | NA | 30 | ambient | 7 | [ |
| 2019 | 2017–2018 | USA | adults | NA | 101 | ambient | 7 | [ |
| 2019 | 2016/2017 | USA | adults | NA | 10 | occupational | 0.83–2.08 | [ |
| 2019 | 2016 | BRA | adults | NA | 2 | ambient | 3 | [ |
| 2019 | 2016 | USA | adults | NA | 10 | ambient | 7 | [ |
| 2019 | 2017 | USA | adults | NA | 22 | ambient | 7 | [ |
| 2019 | 2016 | USA | adolescents | 14–16 | 97 | ambient | 7 | [ |
| 2019 | 2008–? | USA | child-mother pairs | 3–5 | 32 | ambient | 7 | [ |
| 2019 | NR | USA | adults | NA | 10 | ambient | 7 | [ |
| 2019 | 2017 | USA | children | 4–14 | 31 | ambient | 7,2 | [ |
| 2019 | NA | CAN, NED | NA | NA | NA | exposure chamber | 1, 4, 10, 30, 50, 71, 91, 161 | [ |
| 2019 | NA | USA | NA | NA | NA | NA | 7 | [ |
| 2019 | NR | NR | NR | NA | 10 | NR | 7 | [ |
| 2019 | 2016–2017 | CHL | NR | NA | 27 | ambient | 5 | [ |
| 2019 | NR | NR | NR | NA | 16 | ambient | 18 | [ |
| 2020 | 2018 | URY | children | 6–7.8 | 24 | ambient | 7 | [ |
| 2020 | 2019 | JPN | adults | NA | 5 | ambient | 5 | [ |
| 2020 | 2017 | USA | adults | NA | 72 | occupational | 1 | [ |
| 2020 | 2019 | USA | adults | NA | 88 | ambient | 5 | [ |
| 2020 | 2017–2018 | USA | adults | NA | 101 | ambient | 7 | [ |
| 2020 | 2019 | DOM | adults | NA | 15 | occupational | 1 | [ |
| 2020 | 2017–2018 | USA | adults | NA | 255 | ambient | 7 | [ |
| 2020 | 2017–2018 | USA | adults | NA | 20 | ambient | 7 | [ |
| 2020 | 2015/2016 | USA | children | 3–6 | 77 | ambient | 7 | [ |
| 2020 | 2017–2018 | USA | children | 3–14 | 53 | ambient | 7, 2 | [ |
| 2020 | 2018–2019 | FRA | adults | NA | 40 | ambient | 5 | [ |
| 2020 | 2018–2019 | ITA | adults | NA | 31 | ambient | 5 | [ |
| 2020 | 2018 | BGD | adolescents/adults | ≥14 | 15 | occupational | 1 | [ |
| 2020 | 2018 | USA | adults | NA | 30 | ambient | 5 | [ |
| 2020 | 2018 | USA | adults | NA | 17 | occupational | 1 | [ |
| 2020 | 2017 | CAN | adults | NA | 45 | occupational | 0.3 | [ |
| 2021 | 2014–2016 | USA | children | 3–6 | 27 | ambient | 7 | [ |
| 2021 | 2018–2019 | USA | children | 10–17 | 163 | ambient | 7 | [ |
| 2021 | 2018–2019 | CHN | Child-mother pairs | ≤7 | 47 | ambient | 14 | [ |
Note: WBs: n—number of tested samples/participants (NR—not reported, NA—not applicable), *—in accordance with ISO 3166. †—studies described within the same paper, individual tested groups separated in this chart due to reciprocal differentiation in presented variables.
Methodologies applied in reviewed articles (NR—not reported, Y—substances included in the study, N—substances not included in the study).
| Pre-Deployment | Post-Deployment | Extraction | Post-Extraction Sample Cleanup | Analyzed Substances | Instrumental Analysis | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Publication Year | Mechanism | Protocol | Mechanism | Protocol | Mechanism | Protocol | Instrumentation | Protocol | NBRFs | OPEs | PAHs | BFRs | PCBs | PEs | Pesticides | PPCPs | Other | Ref. | |
| 2014 | Agitated wash (orbital shaker) | 3 × EtAc:n-hex (2.5 h), 60 rpm | Rinse | 2 × DI water | Agitated wash (orbital shaker) | 2 × EtAc,100 mL, (2 h), 60 rpm | NR | NR | N | Y | Y | N | Y | Y | Y | Y | Y | GC-MS | [ |
| 2016 | Thermal conditioning | 280–300 °C (48 h) | Rinse | 1 × DI water | NR | 2 × EtAc, 100 mL | NR | NR | N | N | N | N | N | N | Y | N | N | GC-ECD | [ |
| 2016 | Soxhlet extraction | 1 × EtAc:n-hex, (12 h) | NR | NR | Soxhlet extraction | 1 × n-hex:acetone, (12 h) | Syringe filter (0.2 µm PTFE) | Filtration | N | Y | N | N | N | N | N | N | N | GC-MS | [ |
| F1:n-hex (10 mL) | |||||||||||||||||||
| F2:EtAc (10 mL) | |||||||||||||||||||
| 2017 | Wash | 3 × EtAc:n-hex | Rinse | 2 × DI water | Wash | 1 × EtAc, 100 mL, (12 h) | NR | NR | Y | Y | Y | Y | Y | Y | Y | Y | Y | GC-ECD, GC-MS | [ |
| 2017 | Conditioning (vacuum oven) | 300 °C, 180 min, 0.1 Torr | Rinse | 2 × DI water | Agitated wash (orbital shaker) | 2 × EtAc, 100 mL | NR | NR | N | Y | Y | Y | Y | N | Y | Y | Y | GC-MS, GC-MS/MS, GC-µECD | [ |
| 2017 | Soak | EtAc, n-hex, MeOH | Rinse | 2 × water | NR | 2 × EtAc, 100 mL | SPE cartridges (C18, 500 mg) | Elution: ACN | Y | Y | N | Y | N | N | N | N | N | GC-MS | [ |
| 2018 | NR | NR | Rinse | 1 × DI water | Dialysis | 2 × EtAc | NR | NR | N | N | Y | N | N | N | N | N | N | GC-MS/MS | [ |
| 2018 | Solvent exchange | 3 × EtAc:n-hex | Rinse | 2 × DI water | Agitated wash (orbital shaker) | 2 × EtAc 100 mL, 60 rpm | NR | NR | N | N | Y | N | N | N | N | N | N | GC-MS/MS | [ |
| 2018 | Agitated wash (overhead shaker) | 1 × EtAc:n-hex, (30 min) | NR | NR | Agitated wash (overhead shaker) | 2 × EtAc, 40 mL, (30 min) | NR | NR | N | N | N | N | N | N | Y | N | N | LC-MS | [ |
| 2018 | NR | NR | Rinse | 2 × DI water | Wash | 1 × EtAc 100 mL, (12 h) | NR | NR | N | N | N | N | N | N | Y | N | N | GC-µECD | [ |
| 2018 | Soxhlet extraction | 1 × EtAc:n-hex, (12 h) | NR | NR | Sonication | 3 × n-hex:acetone, 10 mL | Custom SPE: Florisil (500 mg) and silica gel (12 g; F1 only) | Elution (Florisil): | Y | N | N | Y | N | N | N | N | N | GC-MS | [ |
| F1:n-hex | |||||||||||||||||||
| F2:EtAc | |||||||||||||||||||
| Elution (silica gel): | |||||||||||||||||||
| 2019 | Rinse, conditioning | Water rinse, thermal conditioning | Rinse | 1 × DI water | Agitated wash (orbital shaker) | 2 × EtAc, 100 mL, (2 h) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | GC-MS | [ |
| 2019 | Soxhlet extraction | 1 × EtAc:n-hex, (24 h) | NR | NR | Sonication | 2 × n-hex:acetone, 30 mL, (2 h) | Custom SPE (neutral alumina, neutral silica gel, sulfuric acid- silica gel, sodium sulfate) | Elution: DCM (40 mL) | Y | Y | N | Y | N | N | N | N | Y | GC-MS | [ |
| Custom SPE (neutral alumina, neutral silica, Florisil, sodium sulfate) | Elution: | ||||||||||||||||||
| F1:DCM (40 mL) | |||||||||||||||||||
| F2:EtAc (40 mL) | |||||||||||||||||||
| 2019 | NR | NR | Rinse | 2 × DI water | Agitated wash (orbital shaker) | 2 × EtAc, 100 mL, 60 rpm | NR | NR | N | Y | Y | N | N | Y | Y | Y | Y | GC-MS | [ |
| 2019 | Thermal conditioning (vacuum oven) | 300 °C, (180 min), 0.1 Torr | Rinse | 1 × DI water | NR | 2 × EtAc, 100 mL | SPE (C18, silica) | Elution: ACN | Y | Y | Y | Y | Y | Y | Y | Y | Y | GC-µECD, GC-MS | [ |
| 2019 | Soak | EtAc, n-hex, MeOH | NR | NR | NR | 2 × EtAc, 100 mL | SPE cartridges (C18, 500 mg) | Elution: ACN | N | Y | N | N | N | N | N | N | N | GC-MS | [ |
| 2019 | Soxhlet extraction | Agitated wash | 1 × DI water | Sonication | 1 × Acetone:n-hex, 20 mL, (2 h) | Custom SPE (neutral alumina, neutral silica, Florisil, anhydrous sodium sulfate) | Elution: | Y | Y | Y | Y | N | N | N | N | Y | GC-MS | [ | |
| F1:DCM | |||||||||||||||||||
| F2:EtAc | |||||||||||||||||||
| Rinse | 1 × IPA | Custom SPE, (neutral alumina, neutral silica, acidic silica, anhydrous sodium sulfate) | elution: | ||||||||||||||||
| 2019 | NR | NR | Rinse | 2 × DI water | Agitated wash (orbital shaker) | 2 × EtAc, 100 mL, (2 h), 60 rpm | - | - | N | N | Y | N | N | Y | Y | N | Y | GC-GC/ToF-MS | [ |
| 2020 | Soxhlet extraction | 1 × EtAc (3 days) | - | - | Agitated wash (Wrist Action Shaker) | 1 × ACN, 30 mL | Syringe filter (0.2 µm, Teflon) | Filtration | Y | Y | N | Y | N | N | N | N | Y | GC-MS | [ |
| 2020 | Agitated wash (platform shaker) | 3 × EtAc:n-hex, (2.5 h) | NR | NR | Agitated wash (orbital shaker) | 2 × EtAc, 25 mL, (2 h), 60 rpm | SPE cartridges (C18, 500 mg) | Elution: ACN | Y | Y | N | Y | Y | N | Y | N | Y | GC-MS | [ |
| 2020 | NR | NR | Rinse | 1 × DI water | Agitated wash (orbital shaker) | 2 × EtAc, 25 mL, (24 h) | SPE cartridges (C18, 500 mg) | Elution: n-hex: DCM (4 mL) | N | N | Y | N | N | N | N | Y | N | GC-MS | [ |
| 2020 | Agitated wash (orbital shaker) | 1 × MeOH (10 min) | Rinse | 1 × MeOH | agitated wash (orbital shaker) | 2 × 30 mL EtAc, 30 mL, (1 h) | NR | NR | N | N | Y | N | N | N | N | N | N | GC-MS | [ |
| 2020 | Soxhlet extraction | 1 × EtAc:n-hex, (12 h) | NR | NR | Sonication | 3 × n-hex: DCM, 10 mL, (15 min) | SPE (Florisil, 8 g) | Elution: | N | Y | N | N | N | N | N | N | N | GC-MS/MS | [ |
| F1:n-hex | |||||||||||||||||||
| F2:EtAc | |||||||||||||||||||
| 2020 | Soxhlet extraction | 1 × EtAc:n-hex, (24 h) | NR | NR | Sonication | 2 × n-hex:acetone, 30 mL, (2 h) | Custom SPE (neutral alumina, neutral silica, Florisil, sodium sulfate) | Elution: DCM | N | N | Y | N | N | N | N | N | N | GC-MS | [ |
| 2020 | Agitated wash (orbital shaker) | 2 × MeOH, (10 min), 120 rpm | Rinse | 1 × MeOH | Agitated wash (overhead shaker) | 2 × EtAc, 30 mL | NR | NR | N | N | Y | N | N | N | N | N | N | GC-MS | [ |
| 2020 | Conditioning (vacuum oven) | 300 °C, (12 h), 0.1 Torr | Rinse | 2 × DI water | NR | 2 × EtAc, 50 mL | SPE cartridges (C18) | Eluted: ACN | N | Y | Y | Y | Y | Y | Y | Y | Y | GC-MS | [ |
| 2020 | Soxhlet extraction | 1 × EtAc:n-hex, (12 h) | NR | NR | Sonication | 3 × n-hex:DCM, 10 mL) | SPE cartridges (Florisil, 500 mg) | Elution: | N | Y | N | N | N | Y | N | N | Y | GC-MS | [ |
| F1: n-hex | |||||||||||||||||||
| F2: EtAc | |||||||||||||||||||
| F3: MeOH | |||||||||||||||||||
| 2020 | NR | NR | Rinse | DI water | Sonication | 2 × n-hex: acetone, 30 mL, (2 h) | Chromatography column (neutral alumina, neutral silica gel, sulfuric acid-silica gel, sodium sulfate) | Elution: DCM | Y | Y | Y | Y | N | N | N | N | N | GC-MS | [ |
| Chromatography column (neutral alumina, neutral silica gel, Florisil, sodium sulfate) | Elution:F1:DCM | ||||||||||||||||||
| F2:EtAc | |||||||||||||||||||
| 2020 | Soxhlet extraction | 1 × pentane (3 days) | - | - | Agitated wash | ACN | SPE cartridge (Florisil, 500 mg) | Elution: EtAc | Y | Y | N | Y | N | N | N | N | Y | GC-MS | [ |
| 2020 | Agitated wash (magnetic stir plate) | 3 × EtAc:n-hex, (30 min), 60 rpm | NR | NR | Agitated wash (magnetic stir plate) | ACN:MeOH, 20 mL, (1 h), 60 rpm | NR | NR | N | N | N | N | N | N | N | N | Y | HPLC | [ |
| 2020 | NR | NR | NR | NR | Sonication | 3 × n-hex:DCM, 10 mL | SPE (Florisil, 8 g) | Elution: | Y | Y | N | Y | Y | Y | Y | N | Y | GC-MS, GC-MS/MS | [ |
| F1: n-hex, | |||||||||||||||||||
| F2: EtAc, | |||||||||||||||||||
| F3: MeOH | |||||||||||||||||||
| 2020 | Agitated wash (orbital shaker) | 1 × MeOH (10 min), 120 rpm | NR | NR | Agitated wash (orbital shaker) | 2 × EtAc, 30 mL, (1 h), 120 rpm | NR | NR | N | N | Y | N | N | N | N | N | N | GC-MS | [ |
| 2021 | Soxhlet extraction | 1 × EtAc:n-hex (12 h) | NR | NR | Sonication | 3 × DCM:n-hex | SPE cartridges (Florisil, 500 mg) | Elution: | N | N | N | N | N | N | N | Y | Y | LC-MS | [ |
| F1 | |||||||||||||||||||
| F2: EtAc | |||||||||||||||||||
| F3 | |||||||||||||||||||
| 2021 | Rinse, conditioning | DI water, 300 °C (180 min) | rinse | 1 × DI water | Agitated wash (orbital shaker) | 2 × EtAc | SPE (C18, silica) | Elution: ACN | N | N | N | N | N | N | Y | N | N | GC-ECD, GC-MS | [ |
| 2021 | Sonication | 3 × DCM:n-hex, (20 min) | NR | NR | Sonication | 2 × DCM: n-hex, 15 mL, (20 min) | SPE cartridges (Florisil, 2 g) | Elution: | N | Y | N | N | N | N | N | N | N | LC-MS | [ |
Abbreviations: ACN, acetonitrile; BFRs, brominated flame retardants; DCM, dichloromethane; DI, deionized; EtAc, ethyl acetate; F1, F2, F3, numeration of fractions eluted (in accordance to their order of elution); IPA, isopropyl alcohol; MeOH, methanol; NBFRs, novel brominated flame retardants; n-hex, n-hexane; OPEs, organophosphate esters; PAHs, polycyclic aromatic hydrocarbons; PCBs, polychlorinated biphenyls; PEs, phthalate esters; PPCPs, pharmaceuticals and personal care products; SPE, solid phase extraction.
Figure 3Groups of pollutants analyzed quantitatively in population studies using silicone wristbands. The proportions were computed after assigning a score of 1 to every group per every paper that included quantitative analysis of at least one analyte from the group. Abbreviations: BFRs, brominated flame retardants; NBFRs, novel brominated flame retardants; OPEs, organophosphate esters; PAHs, polycyclic aromatic hydrocarbons; PCBs, polychlorinated biphenyls; PEs, phthalate esters; PPCPs, pharmaceuticals and personal care products.
Figure 4Comparison of key features of wristbands and other environmental media collected during exposure assessment, based on literature review and judgement of the authors. The inner pentagon represents “low/poor” value, whereas the outer one stands for “high/excellent”. For discussion, see section “Comparison with other matrices”. Abbreviations: AAS, active air sampling.